CAS 1147350-75-1

Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-2,6,7,7a-tetrahydro-2-oxo-, methyl ester, (αS)-

CAS: 1147350-75-1

Formula: C₁₆H₁₆ClNO₃S

Purity: 98%

Color and Shape: Solid

Molecular weight: 337.8211

Ref: IN-DA000F3W

Clopidogrel thiolactone

CAS: 1147350-75-1

Clopidogrel thiolactone

Purity: ≥98%

Molecular weight: 337.82g/mol

Ref: 54-BUP21044

2-Oxo-S-Clopidogrel (Mixture of Diastereomers)

CAS: 1147350-75-1

Formula: C₁₆H₁₆ClNO₃S

Molecular weight: 337.82

Ref: 4Z-C-1399

Clopidogrel thiolactone

CAS: 1147350-75-1

Clopidogrel thiolactone (2-oxoclopidogrel), a P2Y12 receptor inhibitor, is an antiplatelet aggregation compound.

Formula: C₁₆H₁₆ClNO₃S

Purity: 98.79%

Color and Shape: Solid

Molecular weight: 337.82

Ref: TM-T5501

Methyl (alphaS)-α-(2-Chlorophenyl)-2,6,7,7a-tetrahydro-2-oxothieno[3,2-c]pyridine-5(4H)-acetate

Controlled Product

CAS: 1147350-75-1

Applications Methyl (αS)-α-(2-chlorophenyl)-2,6,7,7a-tetrahydro-2-oxothieno[3,2-c]pyridine-5(4H)-acetate is the essential intermediate metabolite from which the active metabolite of Clopidogel is formed.
References Feliste, R., et al.: Thromb. Res., 48, 403 (1987), Savi, P., et al.: Biochem. Pharmacol., 44, 527 (1992), Herbert, J., et al.: Cardiovasc Drug. Rev., 11, 180 (1993), Sugidachi, A., et al.: B. J. Pharmacol., 132, 47 (2001)

Formula: C₁₆H₁₆ClNO₃S

Color and Shape: Neat

Molecular weight: 337.821

Ref: TR-M297650

Clopidogrel thiolactone

CAS: 1147350-75-1

Clopidogrel is a thienopyridine prodrug that inhibits the ADP-induced aggregation of platelets. Clopidogrel is metabolized to its active form, clopidogrel sulfide (clopidogrel thiolactone), by esterases present in human serum and liver. The conversion to the active form is dependent on the presence of an intact disulfide bond. Clopidogrel has been shown to be effective in reducing cardiovascular events in patients with atherosclerosis and in those undergoing percutaneous coronary interventions. Clopidogrel also has anti-platelet activity, which may be due to its ability to inhibit platelet aggregation induced by ADP or arachidonate. This drug is used as an adjunct for treatment of patients who have undergone coronary artery bypass graft surgery or percutaneous coronary intervention, or who are at risk for such procedures.

Formula: C₁₆H₁₆ClNO₃S

Purity: Min. 95%

Molecular weight: 337.82 g/mol

Ref: 3D-XVB35075

2-Oxo Clopidogrel

CAS: 1147350-75-1

Formula: C₁₆H₁₆ClNO₃S

Molecular weight: 337.8

Ref: ST-EA-CP-C2043